2 Patents
- US122801022025Alphavirus Replicon Encoding Chimeric Sars-cov-2 Receptor Binding Domains
VLP Therapeutics, Inc.
0 cites - US121347772024Alphavirus Replicon Vector and Immunotherapy by Administering Same
VLP Therapeutics, Inc.
0 cites
VLP Therapeutics, Inc.
VLP Therapeutics, Inc.